In Practise Logo
In Practise Logo - Blue

Explore our full content library.

Found 12 results in 5ms
Nov 26, 2025

Medpace Holdings: Key Considerations in Selecting a CRO

Current VP of Clinical Operations at Biotech Company
Partner Interview
Medpace•US•Large CapIQVIAICONThermo Fisher ScientificSyneos HealthParexel InternationalFortreaCharles River Laboratories InternationalLonza GroupSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseHealth Care
Sep 19, 2025

AGC Biologics & Western vs Chinese CDMOs

Executive at AGC Biologics
Partner Interview
AGC BiologicsWuXi BiologicsBayerLonza GroupThermo Fisher ScientificSartorius Stedim BiotechMerckPfizerCatalentSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseHealth Care
Aug 18, 2025

Sartorius: Upstream Bioprocessing Market Dominance

Former Senior Product Management Director at Sartorius Stedim Biotech
Partner Interview
Sartorius Stedim Biotech•FR•Large CapDanaherGE AerospacePall CorporationMerckThermo Fisher Scientific3MRepligenLonza GroupRocheSwitching CostsProcess PowerOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth CareIndustrialsMaterials
Jul 30, 2025

Aldevron: mRNA, Plasmids and Synthetic DNA

Former VP of Sales, Aldevron
IP Icon
IP Interview
Danaher•US•Large CapCatalentThermo Fisher ScientificModernaGenscript Biotech CorporationLonza GroupSwitching CostsOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth Care
Jun 26, 2025

Sartorius: Building Customer Lock-In Across the Biotech Lifecycle

Former Account Management Executive at Sartorius Stedim Biotech
Partner Interview
Sartorius Stedim BiotechDanaherThermo Fisher ScientificBioNTech SELonza GroupNovartisSanofiSartorius Stedim BiotechDanaherThermo Fisher ScientificBioNTech SELonza GroupNovartisSanofiSwitching CostsOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth Care
Feb 13, 2025

Lonza, WuXi Biologics & CDMO Global Market: Competitive Landscape Evolution

Executive at AGC Biologics
Partner Interview
Lonza Group•CH•Large CapPfizerEli Lilly andNovo NordiskRocheWuXi BiologicsAGC BiologicsHealth Care
Jan 20, 2025

Lonza: CDMO Market Capacity

Executive at AGC Biologics
Partner Interview
Lonza Group•CH•Large CapCatalentSartorius Stedim BiotechAbbVieAvid BioservicesDanaherThermo Fisher ScientificCharles River Laboratories InternationalSwitching CostsOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth Care
Jan 14, 2025

Danaher vs Thermo Fisher: Plasmid Manufacturing & Gene Therapy Positioning

Former VP of Sales, Aldevron
IP Icon
IP Interview
Danaher•US•Large CapThermo Fisher ScientificLonza GroupCatalentCharles River Laboratories InternationalTwist BioscienceSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseSerial AcquirerHealth Care
Dec 16, 2024

Danaher: Aldevron & DNA Plasmid Manufacturing

Former Director at Aldevron, Danaher
IP Icon
IP Interview
Danaher•US•Large CapSartoriusThermo Fisher ScientificCatalentLonza GroupSwitching CostsOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth Care
Oct 6, 2024

Lifecore Biomedical: Customer Mix, Switching Cost & Power in the CDMO Value Chain

Former Senior VP at Lifecore Biomedical
Partner Interview
Landec•US•Small CapNovo NordiskLonza GroupCatalentHealth Care
Logo
IP Research Analysis
Oct 2, 2024

Danaher Cytiva: History, Moat, and Bundling Pall Filters

In Practise Research
IP ResearchDanaher•US•Large CapThermo Fisher ScientificMerckRepligenLonza GroupSartoriusSartorius Stedim BiotechBio-Rad LaboratoriesSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseSerial AcquirerHealth Care
Sep 25, 2023

MaxCyte: Electroporation Technology, Cell & Gene Therapy & Competition

Former Business Development Technical Expert at MaxCyte
Partner Interview
MaxCyte•US•Small CapLonza GroupBio-Rad LaboratoriesHealth Care

You've reached the end